BTA
Click for more information
0.00% 57.0¢ biota holdings limited

rsv competitor candidate flops (kinda)

  1. cgt2009
    13,916 Posts.
    lightbulb Created with Sketch. 124
    clock Created with Sketch.
    02/06/12
    14:14
    Post #: 10257834
    Mixed results for a RSV competitor candidate.

    Bad for mankind, good for BTA.

    Reminder the only RSV product out there is Synagis, which is the 99th best selling drug in the world (which is not bad for a seasonal affliction).

    Mixed Phase IIb results
    BTA Price at posting: 76.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

SUN ANZ deal to buy Suncorp to go ahead following approval from Treasurer
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
TBN Tamboran is developing the NT Beetaloo Basin. To get there, it's listing at $36/sh on the NYSE
right-arrow Created with Sketch.
ABY Adore Beauty buys up wellness brand iKOU for $25M cash
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.